athenaeumpub

  The Journal of Ophthalmology and Advance Research, published by Athenaeum Scientific Publishers, is a premier open- access platform committed to disseminating cutting- edge findings, reviews, and innovations in the field of ophthalmology and vision science. As a leading name in scientific publishing, Athenaeum Scientific Publishers has cultivated this journal to support academic excellence, research transparency, and global collaboration among clinicians, researchers, and medical professionals. This peer- reviewed journal provides a reliable and dynamic venue for original research articles, case reports, clinical studies, and review papers that explore novel diagnostic techniques, therapeutic advancements, surgical innovations, and emerging technologies in ophthalmic sciences. The Journal of Ophthalmology and Advance Research ensures a rigorous editorial process that maintains high standards of scientific integrity and quality control, under the careful management of experience...

  Introduction: The Role of American Medical Journals in Advancing Therapeutic Frontiers The American Medical Journal remains a cornerstone of evidence- based medicine, publishing breakthrough studies that influence clinical practice worldwide. Among its recent highlights is a detailed exploration of Golimumab monotherapy, a biologic treatment that has garnered attention for its efficacy in managing inflammatory and autoimmune disorders. Published by Athenaeum Scientific Publishers, this article offers new perspectives on the therapeutic potential and safety profile of Golimumab when used as a stand- alone intervention. Understanding Golimumab Monotherapy Golimumab is a fully human monoclonal antibody that targets tumor necrosis factor- alpha ( TNF- α), a cytokine involved in systemic inflammation. It is FDA- approved for several conditions, including rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. While traditionally used in combination with disease- modifyi...